scispace - formally typeset
D

Diana Böhm

Researcher at University of Bonn

Publications -  7
Citations -  1536

Diana Böhm is an academic researcher from University of Bonn. The author has contributed to research in topics: Transcriptome & Prostate cancer. The author has an hindex of 6, co-authored 6 publications receiving 1309 citations.

Papers
More filters
Journal ArticleDOI

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

Martin Peifer, +94 more
- 01 Oct 2012 - 
TL;DR: This study implicates histone modification as a major feature of SCLC, reveals potentially therapeutically tractable genomic alterations and provides a generalizable framework for the identification of biologically relevant genes in the context of high mutational background.
Journal ArticleDOI

Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer.

TL;DR: This analysis revealed distinct transcriptional expression profiles of the Mediator complex across cancer entities indicating differential modes of transcriptional regulation and identified CDK19 and CDK8 to be specifically overexpressed during prostate cancer progression, highlighting their potential as novel therapeutic targets in advanced prostate cancer.
Journal ArticleDOI

Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.

TL;DR: The results of the present study underscore that typing of CaP for the ERG could enhance the understanding of the biologic differences between the examined ethnic groups, and establish a major difference between the index tumors of Caucasian and African American patients.
Journal ArticleDOI

Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data

TL;DR: TRUP (Tumor-specimen suited RNA-seq Unified Pipeline) is developed, a computational approach that combines split-read and read-pair analysis with de novo assembly for the identification of chimeric transcripts in cancer specimens and is found to be more sensitive than alternative tools in detecting chimeric Transcripts.